{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:12:58Z","timestamp":1772766778134,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Topic on Basic and Applied Basic Research in Guangdong Province","award":["SL2023A04J01984"],"award-info":[{"award-number":["SL2023A04J01984"]}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2020M683128"],"award-info":[{"award-number":["2020M683128"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100648, 81870404"],"award-info":[{"award-number":["82100648, 81870404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00639-1","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T06:03:03Z","timestamp":1738908183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B"],"prefix":"10.1186","volume":"20","author":[{"given":"Qianqian","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"2","key":"639_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","volume":"76","author":"HY Kim","year":"2022","unstructured":"Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, et al. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. J Hepatol. 2022;76(2):311\u20138.","journal-title":"J Hepatol"},{"key":"639_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73:4\u201313.","journal-title":"Hepatology"},{"key":"639_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13027-018-0192-7","volume":"13","author":"N Rungsakulkij","year":"2018","unstructured":"Rungsakulkij N, Suragul W, Mingphruedhi S, Tangtawee P, Muangkaew P, Aeesoa S. Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection. Infect Agent Cancer. 2018;13:20.","journal-title":"Infect Agent Cancer"},{"key":"639_CR4","doi-asserted-by":"crossref","unstructured":"Zhuo Y, Chen Q, Chhatwal J. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance. Hepatocellular Carcinoma: Translational Precision Medicine Approaches. Cham (CH): Humana Press 2019. Chapter 3. PubMed PMID: 32078270.","DOI":"10.1007\/978-3-030-21540-8_3"},{"issue":"4","key":"639_CR5","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"6","key":"639_CR6","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.jhepr.2020.100152","volume":"2","author":"VW Hui","year":"2020","unstructured":"Hui VW, Chan SL, Wong VW, Liang LY, Yip TC, Lai JC, et al. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC. JHEP Rep. 2020;2(6):100152.","journal-title":"JHEP Rep"},{"issue":"10","key":"639_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41389-021-00358-3","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang J, Yang R, Cheng Y, Zhou Y, Li H, et al. GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells. Oncogenesis. 2021;10(10):69.","journal-title":"Oncogenesis"},{"key":"639_CR8","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018;69(1):182\u2013236."},{"issue":"1","key":"639_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380.","journal-title":"Hepatology"},{"issue":"4","key":"639_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370.","journal-title":"Hepatol Int"},{"key":"639_CR11","doi-asserted-by":"crossref","unstructured":"Singal AG, Tayob N, Mehta A, Marrero JA, El-Serag H, Jin Q, et al. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. HEPATOLOGY 2022 2022\u201303\u201301;75(3):541\u2013549.","DOI":"10.1002\/hep.32185"},{"issue":"9","key":"639_CR12","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/cam4.2968","volume":"9","author":"Y Ding","year":"2020","unstructured":"Ding Y, Liu K, Xu Y, Zhao Q, Lou S, Xiang X, et al. Combination of inflammatory score\/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Med. 2020;9(9):3057\u201369.","journal-title":"Cancer Med"},{"issue":"2","key":"639_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gutjnl-2016-312653","volume":"67","author":"K Murata","year":"2018","unstructured":"Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, et al. Induction of IFN-\u03bb3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut. 2018;67(2):362\u201371.","journal-title":"Gut"},{"issue":"1","key":"639_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","volume":"5","author":"J Choi","year":"2019","unstructured":"Choi J, Kim HJ, Lee J, Cho S, Ko MJ, Lim YS. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: A Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30\u20136.","journal-title":"JAMA Oncol"},{"issue":"3","key":"639_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jhep.2019.03.028","volume":"71","author":"SU Kim","year":"2019","unstructured":"Kim SU, Seo YS, Lee HA, Kim MN, Lee YR, Lee HW, et al. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-na\u00efve chronic hepatitis B in South Korea. J Hepatol. 2019;71(3):456\u201364.","journal-title":"J Hepatol"},{"issue":"2","key":"639_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cgh.2020.05.008","volume":"19","author":"WM Choi","year":"2021","unstructured":"Choi WM, Choi J, Lim YS. Effects of tenofovir vs entecavir on risk of hepatocellular carcinoma in patients with chronic HBV infection: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(2):246\u201358.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"639_CR17","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/jvh.12971","volume":"25","author":"BG Kim","year":"2018","unstructured":"Kim BG, Park NH, Lee SB, Lee H, Lee BU, Park JH, et al. Mortality, liver transplantation and hepatic complications in patients with treatment-na\u00efve chronic hepatitis B treated with entecavir vs tenofovir. J Viral Hepat. 2018;25(12):1565\u201375.","journal-title":"J Viral Hepat"},{"issue":"2","key":"639_CR18","doi-asserted-by":"publisher","first-page":"e00046","DOI":"10.1128\/CMR.00046-19","volume":"33","author":"MH Nguyen","year":"2020","unstructured":"Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):e00046-e119.","journal-title":"Clin Microbiol Rev"},{"issue":"40","key":"639_CR19","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.3748\/wjg.v25.i40.6041","volume":"25","author":"L Di Tommaso","year":"2019","unstructured":"Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25(40):6041\u201352.","journal-title":"World J Gastroenterol"},{"key":"639_CR20","doi-asserted-by":"crossref","unstructured":"Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline on prevention and treatment of chronic hepatitis B in China. Chin Med J. 2007;120(24):2159\u201373.","DOI":"10.1097\/00029330-200712020-00002"},{"issue":"1","key":"639_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"issue":"1","key":"639_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/hep.28280","volume":"63","author":"AS Lok","year":"2016","unstructured":"Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis. Hepatology. 2016;63(1):284\u2013306.","journal-title":"Hepatology"},{"key":"639_CR23","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67(2):370\u2013398."},{"issue":"3","key":"639_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.7150\/ijms.39775","volume":"17","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yang Z, Wang Z, Dou X, Sheng Q, Li Y, et al. HBV DNA and HBsAg: early prediction of response to peginterferon \u03b1-2a in HBeAg-Negative Chronic Hepatitis B. Int J Med Sci. 2020;17(3):383\u20139.","journal-title":"Int J Med Sci"},{"issue":"4","key":"639_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/gutjnl-2018-316204","volume":"68","author":"K Wang","year":"2019","unstructured":"Wang K, Lu X, Zhou H, Gao Y, Zheng J, Tong M, et al. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut. 2019;68(4):729\u201341.","journal-title":"Gut"},{"issue":"1","key":"639_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/hep.29179","volume":"67","author":"E Herrmann","year":"2018","unstructured":"Herrmann E, de L\u00e9dinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology. 2018;67(1):260\u201372.","journal-title":"Hepatology"},{"issue":"6","key":"639_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","volume":"12","author":"HI Yang","year":"2011","unstructured":"Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, et al. REACH-B Working Group: Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011;12(6):568\u201374.","journal-title":"Lancet Oncol"},{"issue":"4","key":"639_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","volume":"64","author":"G Papatheodoridis","year":"2016","unstructured":"Papatheodoridis G, Dalekos G, Sypsa V, Yurdaydin C, Buti M, Goulis J, et al. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J Hepatol. 2016;64(4):800\u20136.","journal-title":"J Hepatol"},{"issue":"5","key":"639_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","volume":"69","author":"JH Kim","year":"2018","unstructured":"Kim JH, Kim YD, Lee M, Jun BG, Kim TS, Suk KT, et al. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy. J Hepatol. 2018;69(5):1066\u201373.","journal-title":"J Hepatol"},{"issue":"6","key":"639_CR30","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","volume":"73","author":"R Fan","year":"2020","unstructured":"Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020;73(6):1368\u201378.","journal-title":"J Hepatol"},{"issue":"4","key":"639_CR31","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/hep.30083","volume":"68","author":"Y Pang","year":"2018","unstructured":"Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people. Hepatology. 2018;68(4):1308\u201318.","journal-title":"Hepatology"},{"issue":"6","key":"639_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/jac\/dkw019","volume":"71","author":"WJ Jeng","year":"2016","unstructured":"Jeng WJ, Chen YC, Chang ML, Liaw YF. \u03b1-Fetoprotein level-dependent early hepatitis B surface antigen decline during entecavir therapy in chronic hepatitis B with hepatitis flare. J Antimicrob Chemother. 2016;71(6):1601\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"639_CR33","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/liv.14197","volume":"39","author":"A Loglio","year":"2019","unstructured":"Loglio A, Iavarone M, Vigan\u00f2 M, Orenti A, Facchetti F, Cortinovis I, et al. Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy. Liver Int. 2019;39(10):1964\u201374.","journal-title":"Liver Int"},{"issue":"3","key":"639_CR34","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jhep.2022.12.007","volume":"78","author":"WM Choi","year":"2023","unstructured":"Choi WM, Yip TC, Wong GL, Kim WR, Yee LJ, Brooks-Rooney C, et al. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis. J Hepatol. 2023;78(3):534\u201342.","journal-title":"J Hepatol"},{"issue":"6","key":"639_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/apt.12629","volume":"39","author":"L Gao","year":"2014","unstructured":"Gao L, Trinh HN, Li J, Nguyen MH. Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. Aliment Pharmacol Ther. 2014;39(6):629\u201337.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"639_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13643-019-1126-1","volume":"8","author":"WWL Wong","year":"2019","unstructured":"Wong WWL, Pechivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, et al. Antiviral treatment for treatment-na\u00efve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2019;8(1):207.","journal-title":"Syst Rev"},{"issue":"1","key":"639_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12876-017-0596-7","volume":"17","author":"JW Park","year":"2017","unstructured":"Park JW, Kwak KM, Kim SE, Jang MK, Suk KT, Kim DJ, et al. Comparison of the long-term efficacy between entecavir and tenofovir in treatment- na\u00efve chronic hepatitis B patients. BMC Gastroenterol. 2017;17(1):39.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"639_CR38","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.cgh.2022.07.005","volume":"21","author":"HSJ Choi","year":"2023","unstructured":"Choi HSJ, Hirode G, Chen CH, Su TH, Seto WK, Van Hees S. Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B. Clin Gastroenterol Hepatol. 2023;21(6):1513-1522.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"639_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2020.06.011","volume":"73","author":"GV Papatheodoridis","year":"2020","unstructured":"Papatheodoridis GV, Dalekos GN, Idilman R, Sypsa V, Van Boemmel F, Buti M. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. J Hepatol. 2020;73(5):1037\u201345.","journal-title":"J Hepatol"},{"issue":"10","key":"639_CR40","doi-asserted-by":"publisher","first-page":"e2340353","DOI":"10.1001\/jamanetworkopen.2023.40353","volume":"6","author":"P Li","year":"2023","unstructured":"Li P, Wang Y, Yu J, Yu J, Tao Q, Zhang J, et al. Tenofovir vs entecavir among patients with HBV-related HCC after resection. JAMA Netw Open. 2023;6(10):e2340353.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"639_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3138\/canlivj-2023-0003","volume":"6","author":"C Fernandes da Silva","year":"2023","unstructured":"Fernandes da Silva C, Keeshan A, Cooper C. Hepatitis B virus genotypes influence clinical outcomes: a review. Can Liver J. 2023;6(3):347\u201352.","journal-title":"Can Liver J"},{"issue":"15","key":"639_CR42","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1002\/cam4.2543","volume":"8","author":"J An","year":"2019","unstructured":"An J, Chang S, Kim HI, Song GW, Shim JH. The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease. Cancer Med. 2019;8(15):6624\u201333.","journal-title":"Cancer Med"},{"issue":"2","key":"639_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","volume":"70","author":"N Ganne-Carri\u00e9","year":"2019","unstructured":"Ganne-Carri\u00e9 N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019;70(2):284\u201393.","journal-title":"J Hepatol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00639-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00639-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00639-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:20:34Z","timestamp":1772763634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00639-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00639-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5217237\/v1","asserted-by":"object"}]},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The grant number of Special Topic on Basic and Applied Basic Research in Guangdong Province has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"8"}}